397 related articles for article (PubMed ID: 9837732)
1. The fibronectin type III domain as a scaffold for novel binding proteins.
Koide A; Bailey CW; Huang X; Koide S
J Mol Biol; 1998 Dec; 284(4):1141-51. PubMed ID: 9837732
[TBL] [Abstract][Full Text] [Related]
2. FN3: a new protein scaffold reaches the clinic.
Bloom L; Calabro V
Drug Discov Today; 2009 Oct; 14(19-20):949-55. PubMed ID: 19576999
[TBL] [Abstract][Full Text] [Related]
3. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
4. Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain.
Koide A; Koide S
Methods Mol Biol; 2007; 352():95-109. PubMed ID: 17041261
[TBL] [Abstract][Full Text] [Related]
5. Design of novel FN3 domains with high stability by a consensus sequence approach.
Jacobs SA; Diem MD; Luo J; Teplyakov A; Obmolova G; Malia T; Gilliland GL; O'Neil KT
Protein Eng Des Sel; 2012 Mar; 25(3):107-17. PubMed ID: 22240293
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional studies of titin's fn3 modules reveal conserved surface patterns and binding to myosin S1--a possible role in the Frank-Starling mechanism of the heart.
Muhle-Goll C; Habeck M; Cazorla O; Nilges M; Labeit S; Granzier H
J Mol Biol; 2001 Oct; 313(2):431-47. PubMed ID: 11800567
[TBL] [Abstract][Full Text] [Related]
7. Engineered protein scaffolds for molecular recognition.
Skerra A
J Mol Recognit; 2000; 13(4):167-87. PubMed ID: 10931555
[TBL] [Abstract][Full Text] [Related]
8. Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two.
Parker MH; Chen Y; Danehy F; Dufu K; Ekstrom J; Getmanova E; Gokemeijer J; Xu L; Lipovsek D
Protein Eng Des Sel; 2005 Sep; 18(9):435-44. PubMed ID: 16087651
[TBL] [Abstract][Full Text] [Related]
9. Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffold.
Juraja SM; Mulhern TD; Hudson PJ; Hattarki MK; Carmichael JA; Nuttall SD
Protein Eng Des Sel; 2006 May; 19(5):231-44. PubMed ID: 16549402
[TBL] [Abstract][Full Text] [Related]
10. Modularity and homology: modelling of the titin type I modules and their interfaces.
Amodeo P; Fraternali F; Lesk AM; Pastore A
J Mol Biol; 2001 Aug; 311(2):283-96. PubMed ID: 11478861
[TBL] [Abstract][Full Text] [Related]
11. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan.
Hopf M; Göhring W; Mann K; Timpl R
J Mol Biol; 2001 Aug; 311(3):529-41. PubMed ID: 11493006
[TBL] [Abstract][Full Text] [Related]
12. High level expression and rational mutagenesis of a designed protein, the minibody. From an insoluble to a soluble molecule.
Bianchi E; Venturini S; Pessi A; Tramontano A; Sollazzo M
J Mol Biol; 1994 Feb; 236(2):649-59. PubMed ID: 8107147
[TBL] [Abstract][Full Text] [Related]
13. Engineering fibronectin-based binding proteins by yeast surface display.
Chen TF; de Picciotto S; Hackel BJ; Wittrup KD
Methods Enzymol; 2013; 523():303-26. PubMed ID: 23422436
[TBL] [Abstract][Full Text] [Related]
14. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
Korndörfer IP; Beste G; Skerra A
Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
[TBL] [Abstract][Full Text] [Related]
15. Structural studies on a protein-binding zinc-finger domain of Eos reveal both similarities and differences to classical zinc fingers.
Westman BJ; Perdomo J; Matthews JM; Crossley M; Mackay JP
Biochemistry; 2004 Oct; 43(42):13318-27. PubMed ID: 15491138
[TBL] [Abstract][Full Text] [Related]
16. Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library.
Atwell S; Ridgway JB; Wells JA; Carter P
J Mol Biol; 1997 Jul; 270(1):26-35. PubMed ID: 9231898
[TBL] [Abstract][Full Text] [Related]
17. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
[TBL] [Abstract][Full Text] [Related]
18. Structure and energetics of an allele-specific genetic interaction between dnaJ and dnaK: correlation of nuclear magnetic resonance chemical shift perturbations in the J-domain of Hsp40/DnaJ with binding affinity for the ATPase domain of Hsp70/DnaK.
Landry SJ
Biochemistry; 2003 May; 42(17):4926-36. PubMed ID: 12718534
[TBL] [Abstract][Full Text] [Related]
19. A small bispecific protein selected for orthogonal affinity purification.
Alm T; Yderland L; Nilvebrant J; Halldin A; Hober S
Biotechnol J; 2010 Jun; 5(6):605-17. PubMed ID: 20518064
[TBL] [Abstract][Full Text] [Related]
20. Exploring the potential of the monobody scaffold: effects of loop elongation on the stability of a fibronectin type III domain.
Batori V; Koide A; Koide S
Protein Eng; 2002 Dec; 15(12):1015-20. PubMed ID: 12601141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
